Turka Laurence A.
- SEC CIK
- 0001800952
No open-market purchases or sales filed in the past year.
Current role at each company
- RUBY Rubius Therapeutics, Inc.Chief Scientific Officeras of Jan 31, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Turka Laurence A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 (view filing)9:50 PM ET | Jan 31 | Same day | Turka Laurence A.Chief Scientific Officer | SSale | −2.59K | $0.24 | −$622.32 | −12.4%18.4K after | |
| Feb 1, 2022 (view filing) | Feb 1 | Same day | Turka Laurence A.Chief Scientific Officer | SSale | −2.52K | $6.57 | −$16.5K | −33.8%4.92K after |